PPB - Services

Complaints, Feedback and Enquiry

Public Notice on Falsified Batches of Truvada (Emtricitabine/ Tenofovir 200mg/300mg) Product

[featured_image]
  • Version
  • Download 86
  • File Size 1.58 MB
  • File Count 1
  • Create Date November 22, 2023
  • Last Updated November 22, 2023

Public Notice on Falsified Batches of Truvada (Emtricitabine/ Tenofovir 200mg/300mg) Product

The Pharmacy and Poisons Board (PPB) wishes to alert the public about suspicious batches of falsified and substandard (SF) Truvada product suspected to be circulating within the Kenyan market. The product batches in question are TRUVADA 200mg/300mg tablets (Emtricitabine 200mg/Tenofovir Disoproxil 300mg) manufactured by Gilead Sciences Inc. bearing the Batch numbers B4033894D and B425875D.

Attached Files

FileAction
Public Notice on Falsified Batches of Truvada (Emtricitabine: Tenofovir 200mg:300mg) Product.pdfDownload

Author

Tony Kemboi

Leave a comment

Your email address will not be published. Required fields are marked *